Rajdeep Banerjee

Dr. Rajdeep Banerjee

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 February 2025 in SynBio
Verified
Journal Article
Open access
PDF file
RBRajdeep Banerjee
Rajdeep Banerjee
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial pathogenesis and developing effective therapies. This review underscores the potential of synthetic biology in elucidating host–pathogen interactions and facilitating the creation of advanced diagnostic tools and targeted therapies to combat MDR infections. We first explore CRISPR-based strategies that modulate essential gene expression, providing insights into the molecular mechanisms underlying host–pathogen interactions. Next, we discuss engineered microbial synthetic circuits for rapid pathogen detection by identifying molecular signatures involved in interspecies communication and facilitating swift pathogen elimination. Additionally, we explore phage therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the application of organ-on-a-chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physiology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine. Collectively, these synthetic biology tools provide transformative insights into the molecular mechanisms of host–pathogen interactions, advancing the development of precise diagnostic and therapeutic strategies against MDR infections.

5 May 2025 in Non-Coding RNA
Verified
Journal Article
Open access
PDF file
RBRajdeep Banerjee
Rajdeep Banerjee
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as posttranscriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host–pathogen interactions. Firstly, it examines how sRNAs regulate pathogenicity by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems, followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and membrane modifications, which contribute to multi-drug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and interspecies communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by sRNAs is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.

4 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
RBRajdeep Banerjee
Rajdeep Banerjee
Bacterial pathogens have evolved diverse strategies to infect hosts, evade immune responses, and establish successful infections. While the role of transcription factors in bacterial virulence is well-documented, emerging evidence highlights the significant contribution of small regulatory RNAs (sRNAs) in bacterial pathogenesis. These sRNAs function as post-transcriptional regulators that fine-tune gene expression, enabling bacteria to adapt rapidly to challenging environments. This review explores the multifaceted roles of bacterial sRNAs in host-pathogen interactions. Firstly, it examines how sRNAs regulate virulence by modulating the expression of key virulence factors, including fimbriae, toxins, and secretion systems followed by discussing the role of sRNAs in bacterial stress response mechanisms that counteract host immune defenses, such as oxidative and envelope stress resistance pathways. Additionally, this review investigates the involvement of sRNAs in antibiotic resistance by regulating efflux pumps, biofilm formation, and target modifications, which contribute to multidrug resistance phenotypes. Lastly, this review highlights how sRNAs contribute to intra- and inter-species communication through quorum sensing, thereby coordinating bacterial behavior in response to environmental cues. Understanding these regulatory networks governed by small RNAs (sRNAs) is essential for the development of innovative antimicrobial strategies. This review highlights the growing significance of sRNAs in bacterial pathogenicity and explores their potential as therapeutic targets for the treatment of bacterial infections.

9 February 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
EFEvrim Fer
Evrim Fer
RBRajdeep Banerjee
Rajdeep Banerjee
KHKatsumi Hagino
Katsumi Hagino
KMKaitlyn M. McGrath
Kaitlyn M. McGrath
BKBetul Kacar
Betul Kacar
Terminal extensions are recurrent features in protein evolution, often linked to environmental adaptation and novel regulatory or interaction functions. Here, we combine comparative genomics, structural modeling, and functional assays to elucidate the evolutionary diversification and functional significance of one of the key proteins of all cells, translation initiation factor 2 (IF2) terminal extensions across the tree of life. Specifically, we reconstruct the first comprehensive evolutionary map of IF2 across life, analyzing ∼800 homologs and classify seven distinct structural architectures of IF2 based on extension regions. These extensions are enriched for intrinsically disordered and phase-separation–promoting residues, suggesting roles beyond the conserved catalytic core. Further, functional characterization of IF2 with varying N-terminal lengths show that loss of the N-terminal extension slows bacterial growth specifically under temperature and pH stress. Appending C-terminal extensions from different organisms to the Escherichia coli IF2 demonstrates a conserved role for these extensions in adaptation to temperature and anaerobiosis. Our findings establish the functional significance of IF2 terminal extensions, linking their evolutionary diversification to stress-dependent regulation of translation.

17 December 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
RBRajdeep Banerjee
Rajdeep Banerjee
The increasing prevalence of multi-drug-resistant (MDR) bacterial pathogens presents a critical global health threat, highlighting the urgent need for innovative approaches to understanding bacterial patho-genesis and developing effective therapies. This review explores the potential of synthetic biology as a promising tool for investigating host-pathogen interactions and offering alternative therapeutic solu-tions for MDR infections. We first examine the progress of CRISPR-based strategies that have enabled modulation of essential gene expression, providing insights into the molecular mechanisms underly-ing host-pathogen interactions. We then discuss the use of engineered microbial synthetic circuits for rapid pathogen detection, which identify molecular signatures involved in interspecies communica-tion and facilitate swift pathogen elimination. Additionally, we explore the potential of Phage Therapy (PT), which leverages bacteriophages to selectively target and eliminate specific bacterial pathogens, presenting a targeted and promising approach to combat MDR infections. Finally, we review the appli-cation of Organ-On-A-Chip (OOAC) technology, which overcomes the limitations of animal models in predicting human immune responses by using microfluidic devices that simulate organ-level physi-ology and pathophysiology, thereby enabling more accurate disease modeling, drug testing, and the development of personalized medicine.

5 June 2026 in bioRxiv
Verified
Preprint
Open access
EKElias I. Kemna
Elias I. Kemna
RBRajdeep Banerjee
Rajdeep Banerjee
BKBetul Kacar
Betul Kacar
Nitrogenase is essential for biological nitrogen fixation and a key target for improving sustainable agriculture. The structural and functional complexity of nitrogenase makes it difficult to identify regions that can be engineered without disrupting activity, stability, or complex assembly. To address this challenge, we used an evolution-guided approach to identify lineage-specific regions with potential engineering tolerance, revealing a NifK N-terminal extension as a tunable interface. By generating variant libraries exceeding 9,000 members and evaluating them through diazotrophic growth assays and in-vitro characterization, we show that NifK extension is required for nitrogenase activity while remaining broadly tolerant to mutation, revealing a sequence-function landscape that is both flexible and constrained. A subset of residues at the NifD-NifK interface are critical for maintaining complex stability. Structural analyses indicate that the extension stabilizes the MoFe complex via co-evolved electrostatic interactions, and targeted mutations can improve both enzymatic activity and thermostability. These findings identify the NifK extension as a tunable interface, providing a strategy for engineering more robust nitrogenase variants.